Super-Ingenuity (SPI)

CNC Machining & Injection Molding — DFM/Moldflow Support, CMM Inspection, Prototype to Production Solutions.

ISO 9001 & IATF 16949 CERTIFIED
+(86) 0769 8166 7180 / [email protected]
24h Quote · Free DFM/Moldflow Feedback · CMM Inspection Reports · Global Shipping
Get Instant Quote

CAD Ready: STEP, IGES, STL supported

Medical Injection Molding Case Studies

CTQ-Controlled Programs, Cleanroom Workflow, and Validation-Ready Manufacturing Evidence

Medical injection molding validation scene with clean handling and inspection evidence

These medical injection molding case studies cover catheter connectors, micro-molded housings, and two-shot syringe components, with focus on CTQ dimensions, inspection methods, lot traceability, and validation-ready manufacturing evidence before production release.

The cases below help engineering and sourcing teams review where sealing integrity, dimensional stability, assembly interface control, and document readiness were managed through pressure testing, optical or CMM measurement, and document packages such as FAI, material certification, CoC, or trial records before tooling approval.

Medical DFM review before tooling release Sample quality documents for supplier qualification
Case Project Resin / Process Logic Critical-to-Quality (CTQ) Inspection Method Validation Evidence
Catheter Connector Medical Grade TPU / Overmolding Sealing Diameter & Adhesion 1.0 Bar Pressure Test / Shore A FAI Trial Report Material Cert
Drug Delivery Housing PEEK / Thin-Wall Stability & Sterilization Resistance Sealing Face Flatness & Snap-Fit Position Optical Measurement / CMM Material Cert CoC FAI
Safety Syringe PP+TPE / Multi-Component 2K Molding Soft/Hard Interface Locking Consistency Assembly Force Check / Fit Verification Lot Traceability IQ/OQ Support CoC

Medical Molding Evidence Buyers Review Before RFQ

What these case studies prove

  • Coverage includes catheter connectors, micro-molded housings, syringe components, and regulated polymer applications with fit, sealing, or sterilization constraints.
  • CTQ review covers sealing diameters, fit interfaces, micro-features, material behavior, and process window limits before tooling release.
  • Reviewable evidence includes FAI records, material certification, CoC, lot traceability, trial records, and inspection results prior to production release.

Typical medical parts covered

  • Catheter connectors and fluid delivery interfaces.
  • Micro-molded drug delivery housings with fit-critical dimensions and stability-sensitive features.
  • Safety syringe components and functional assemblies.
  • Insert-molded medical subcomponents for device integration.
  • Fit-critical disposable device parts requiring sterilization compatibility.

What manufacturing evidence is included

  • Part function reviewed together with CTQ features, tolerance stack-up risk, and assembly interface intent.
  • Definition of CTQ features and tolerance stack-up risks.
  • Specific molding/process route and tooling strategy.
  • Inspection methods including CMM, optical measurement, and leak testing.
  • Traceability control logic and lot numbering.
  • Documentation scope including FAI, material certification, CoC, and trial records.
  • Measured results including leak-test pass rate, dimensional conformance on CTQ features, and yield stability by lot.
Medical DFM review before tooling release Sample quality documents for supplier qualification

Case Study 1: Medical Catheter Connector Overmolding

Medical catheter connector overmolding detail showing sealing interface and bond coverage
Sealing Interface & Overmold Bond Detail

Project Background

This project involved a catheter connector used in disposable medical sets, where sealing reliability and tubing retention directly affected fluid path performance. As the component interfaces with standard luer locks and includes an overmolded grip surface, the injection molding route was selected to achieve repeatable sealing geometry, stable overmold coverage, and a single-piece production flow that reduced assembly-related leak risk.

CTQ Requirements & Sealing Risks

In this application, leakage, air ingress, or loss of tube retention would directly affect fluid path reliability. Our DFM and quality control focused on these Critical-to-Quality (CTQ) parameters:

  • Sealing Diameter: ±0.03mm tolerance to prevent fluid bypass or air ingress.
  • Barb Interface: Controlled sharpness and pitch consistency for tubing retention.
  • Overmold Coverage: Full circumferential coverage required at the sealing interface, with optical inspection used to check flash, voids, or incomplete overmold areas that could create leak paths.
  • Pull-off Retention: Mechanical interlocking strength verified to withstand 15N+ disconnection force.
Catheter connector leak test fixture used for 1.0 bar validation checks
1.0 Bar Pressure Validation Fixture

Material & Process Selection

To support the customer’s biocompatibility and sterilization requirements, the material selection was aligned to a Polycarbonate (PC) substrate and medical-grade TPU (90A Shore) overmold. This material pairing was selected to support sealing stability, grip function, and compatibility with EtO and gamma processing requirements defined for the program.

Inspection Method & Validation Evidence

Quality verification was integrated into every production lot. We utilized calibrated pin gauges for luer ID checks and high-resolution optical measurement systems for 360-degree inspection. Validation deliverables included:

  • Full FAI: First Article Inspection was completed across all 32 cavities for sealing diameter, barb interface geometry, and overmold coverage consistency.
  • Pressure Test Records: Lot-level leak testing at 1.0 bar with pass/fail criteria recorded by lot and linked to production traceability.
  • Traceability Matrix: Cavity-specific records were linked to resin lot, material certification, and revision-controlled production history.
Leak-Test Performance 99.98% Pass Rate During Validated Runs at 1.0 Bar
Process Capability Cpk > 1.67 on Sealing Diameter Monitoring
Traceability Boundary Cavity-Level Data tied to Material Certs
Change Control Revision-Controlled Production History

Case Study 2: Thin-Wall Micro-Molded Drug Delivery Housing

Micro-molded drug delivery housing under optical inspection for thin-wall critical features
Optical Verification of Micro-Features

Project Background

This project focused on a drug delivery device housing with micro-features and 0.4 mm thin-wall sections, where dimensional stability directly affected dosing mechanism alignment. Because the housing directly located the dosing mechanism, dimensional shift, warpage, or cumulative tolerance error could cause jamming or dosage inaccuracy, making process window validation a top priority for the engineering team.

CTQ Requirements & Dimensional Risks

We identified functional Critical-to-Quality (CTQ) areas and manufacturing risks prior to tooling:

  • Sealing Face & Snap Fits: Maintaining sealing interface consistency and secure assembly engagement with 0.05 mm interference.
  • Micro Ribs & Alignment Bosses: High-aspect-ratio features requiring complete fill and controlled venting to reduce gas traps, short shots, and burn risk.
  • Tolerance Stack-up: Controlling cumulative variation across mating interfaces to ensure functional mechanism travel.
  • Warpage Risk: Addressing potential shrinkage mismatch due to non-uniform geometry and gating balance.

Tooling Strategy for Thin-Wall & Micro Features

For this geometry, venting efficiency, fill balance, and thermal control had to be tightened beyond standard molding conditions. Our strategy included:

  • Cavity Layout Logic: Balanced runner system with sub-gates to ensure simultaneous cavity filling and uniform packing pressure.
  • Venting Strategy: Porous steel inserts and venting pins were applied around micro-rib features to reduce burn marks, trapped gas, and incomplete fill.
  • Fill Balance: Scientific molding DOE to define the tightest process window for critical wall sections.
Medical DFM review for thin-wall and micro-feature molding

Inspection Method, Sterilization & Documentation

To check manufacturing consistency, we used an inspection route combining optical screening, CMM verification, and post-process checks:

  • Automated Optical System: 100% screening was applied to defined micro-feature presence and flash-sensitive areas during controlled production runs.
  • Metrology: CMM verification for feature-to-feature true position and profile tolerances against master CAD.
  • Post-Autoclave Dimensional Verification: Critical dimensions were rechecked after autoclave exposure to monitor material shift and warpage risk.
  • Documentation & Process Evidence: Documentation included trial records and material traceability. Process evidence included FAI results and capability study data on defined critical features.
Tolerance feasibility for fit-critical molded features
Validation Metric Target Requirement Achieved Outcome
Tolerance Band ±0.02 mm (Critical Features) ±0.015 mm Achieved During Controlled Pilot Validation Runs
Production Yield > 98% First Pass 99.4% First-Pass Yield During Pilot Production Monitoring
Repeatability Cpk ≥ 1.33 Cpk 1.58 During Validated Pilot Run
Validation Status Pilot Run Approval Approved to Proceed to Production Ramp Based on Pilot Run Results

Case Study 3: Two-Shot Medical Safety Syringe Component

Two-shot medical molding cell with insert control and cavity pressure monitoring
2K Cell for Insert Control and Interface Repeatability

Project Background

This program involved a multi-component safety syringe assembly in which a two-shot (2K) process integrated the rigid body and soft interface features required for grip, sealing, and locking performance. A two-shot process was selected over traditional secondary assembly to reduce manual handling steps, lower contamination exposure, and improve interface alignment consistency in high-volume production.

CTQ Requirements & Assembly Control

  • Alignment Surfaces: Rotating platen alignment was controlled to maintain interface registration and reduce flash risk at the 2K transition zone.
  • Locking Feature: Engineering critical dimensions were maintained for the "click-lock" engagement mechanism to ensure functional safety triggers.
  • Tactile Consistency: Shore A hardness control within ±3 points to ensure repeatable user feedback during device activation.
  • Soft/Hard Interface: The PP-TPE interface was designed for consistent mechanical retention and material compatibility, with inspection focused on bond-line continuity and interface defects.
  • Assembly Reliability: Retention force and locking engagement were verified against the program’s functional test criteria during controlled production and validation runs.
Two-shot safety syringe interface showing soft-hard transition and locking detail
Hard-Soft Bond & Locking Interface Detail

Two-Shot Molding Cell & Process Controls

Production ran in a dedicated fully-automated 2K molding cell configured to control insert orientation, interface repeatability, and part handling consistency. To ensure stability, we implemented:

  • Insert Loading & Poka-Yoke: Sensor-based verification was used to detect misloading or incorrect orientation of inserts and mating components during the cycle.
  • Process Stability: Scientific molding DOE to balance cycle time (18s) with dimensional repeatability on functional interfaces.
  • Closed-Loop Control: Real-time cavity pressure monitoring to detect short shots or over-packing instantly at the machine level.

Inspection, Lot Traceability & Change Control

In alignment with customer quality-system expectations, the assembly workflow included lot traceability, revision-controlled records, and documented engineering change handling:

  • Assembly Verification: Functional lot-level testing checked locking engagement, tactile response, and release behavior based on defined sampling plans.
  • Dimensional Checks: Automated vision systems for critical mating surface and interface alignment verification.
  • Lot/Revision Tracking: Cavity-specific data was linked to material lot, operator shift, and revision-controlled production history.
  • Engineering Change Handling: Formal ECO/ECN process for all tool or process modifications during the production lifecycle.
Production OEE > 88.5% During Monitored Production
Defect Rate < 150 PPM During Production Ramp
Traceability Level Cavity & Revision Specific History

*Compliance Note: SPI provides comprehensive manufacturing evidence and process validation records. Final device-level clinical validation remains under the OEM responsibility.

Validation Evidence for Medical Molding Supplier Qualification

Beyond capability claims, we provide the following records, inspection logic, and document packages typically reviewed during supplier qualification for medical molding programs.

CTQ Definition Before Steel Cut

During DFM review, Critical-to-Quality (CTQ) features are defined with the customer team around sealing interfaces, fit-critical dimensions, micro-features, and tolerance stack-up sensitivity so that tooling, gating, and inspection planning follow the same control logic.

  • How CTQs are Defined: Identification based on assembly fit, sealing interfaces, tolerance stack-up sensitivity, and customer-defined functional risk areas.
  • Function-Critical Features: Emphasis on micro-geometries, mating interfaces, and sterilization-sensitive features.
  • The Evidence Chain: We link CTQ definitions directly to the mold design, gating strategy, and the subsequent inspection and validation plan.

Inspection Methods by Feature Type

Feature Type Typical Risk Inspection Method Record Type
Sealing Interfaces Fluid leakage / Air ingress Pin Gauge / Pressure Test Pass/Fail Data (Lot Specific)
Precision Mating Assembly failure / Interference CMM / Multi-Sensor Metrology for True Position and Profile FAI Dimensional Report on Defined CTQs
Micro-Features Short shot / Feature deformation Optical Measurement System Optical Inspection Record / Image Archive
Surface Texture Functional grip / Aesthetic defect Visual Standard / Gloss Meter Visual Standard Check Record / Surface Inspection Log

Traceability, Revision Control & Lot Records

For medical molding programs, traceability records are maintained by shipment lot, cavity ID, material lot, and documented process change history:

  • Lot Traceability: Every shipment is traceable to raw material lot numbers and production shift data.
  • Cavity Identification: In-mold cavity IDs allow for feature-to-cavity performance correlation and defect isolation.
  • Revision and Change History: Documented mold modifications, material/process changes, and ECN/ECO records from trial stages through pilot and production release.

Typical Deliverables Matrix

Document Package Availability Phase Evidence Supported
DFM & Moldflow Summary Pre-Tooling Kickoff Design feasibility and functional risk mitigation
FAI (First Article Inspection) T1 / Pilot Run Full dimensional verification against drawing specifications
Material Cert & CoC Every Shipment Material identity confirmation and shipment traceability
Validation Support (IQ/OQ/PQ) Pilot Run / Ramp-Up (Where Applicable) Customer-specific validation and document submission where applicable

Cleanroom, Quality System, and Manufacturing Responsibility Boundaries

When Cleanroom Molding is Required

Our environmental control strategy is based on the technical risks of the component's end-use rather than generic marketing labels. The manufacturing environment is selected according to contamination sensitivity, packaging route, and customer-defined risk levels:

  • Contamination-Sensitive Parts: Typically considered for optical components, fluid-path connectors, and customer-defined high-cleanliness medical components.
  • Transfer & Cleanliness Conditions: Part transfer conditions are defined around molding, packaging, assembly, and sterilization routes (such as Gamma or EtO) so that cleanliness exposure remains consistent with customer requirements.
  • Risk-Based Selection: Not every medical part automatically requires a cleanroom; we support selection based on documented contamination risk and downstream processing needs.

ISO 13485 and QMSR Quality Documentation Alignment

Our quality management system is structured to support controlled setup records, production records, verification records, and revision-managed documentation for medical molding programs:

  • Controlled Records: Setup records, verification logs, and approved work instructions are maintained under strict revision control for all defined medical programs.
  • U.S. Quality Terminology: For U.S.-based partners, manufacturing communication and document terminology are aligned with customer quality-system expectations to ensure inspection reports, FAI packages, and material certificates are easier to review during supplier qualification.
  • Traceability & Training: Lot-level manufacturing history is linked to defined operator training records and verified process settings.

Manufacturer (SPI) vs. OEM Responsibility Matrix

A successful medical program requires a clear definition of responsibility between manufacturing control and legal regulatory responsibility:

Manufacturer (SPI) Responsibility OEM / Legal Manufacturer Responsibility
Manufacturing Control
  • Molding process stability via documented setup control and process-window monitoring.
  • In-process and final metrology inspection against defined CTQs.
  • Lot & cavity-level traceability record retention.
  • Manufacturing record support for customer Device History Records (DHR).
 Regulatory & Legal Control
  • Final device-level regulatory registration and submission.
  • FDA / EU MDR filing and Legal Manufacturer responsibility.
  • Product-specific clinical validation and safety claims.
  • Post-market surveillance and device marketing authorization.

Common Medical Injection Molding Failure Risks Buyers Review Before Tool Approval

Leakage and Sealing Drift

Medical connector sealing interface showing fit variation and potential leak-path risk

Sealing stability is the primary engineering risk in medical fluid path components. We control leak-path risks by analyzing:

  • Fit/Diameter Variation: Tolerance stack-up at luer interfaces leading to leak-path risk, including air ingress or fluid bypass.
  • Overmold Flash: Flash or particulate at the parting line that disrupts the sealing interface and creates leak-path risk.
  • Detection Method: Leak testing, pin-gauge checks, and visual inspection at sealing features are used to confirm interface consistency by lot.

Sterilization-related Warpage

Medical molded part comparison showing dimensional shift after post-process exposure

Components passing FAI may still shift after secondary processing. We evaluate stability under:

  • Process Exposure: Dimensional shift or stress relaxation after customer-required autoclave, EtO, or other post-process exposure routes.
  • Residual Stress: Non-uniform cooling leading to delayed warpage or geometry drift post-sterilization.
  • Verification Logic: Critical dimensions are rechecked after defined post-process exposure to monitor warpage and material shift.

Overmold Bonding Inconsistency

Overmold interface detail showing bond-line inconsistency and retention-critical geometry

Material separation at soft-hard interfaces can lead to assembly instability or contamination-sensitive gaps:

  • Material Compatibility: Selecting resin pairs with compatible processing behavior and interface performance for the defined load conditions.
  • Geometry Lock: Designing mechanical interlocks when bonding alone is insufficient for functional retention.
  • Inspection Focus: Bond-line continuity, interface flash, and retention performance are checked on defined critical zones.

Contamination & Packaging Transfer

Medical molding handling boundary showing controlled transfer and packaging exposure points

Particulate control and cleanliness exposure are critical manufacturing boundaries for medical programs:

  • Packaging Handoff: Risks during transfer from molding to controlled primary packaging or downstream assembly handling.
  • Control Point: Handling zones, transfer trays, and packaging handoff points are defined to reduce particulate exposure during movement.
  • Handling Protocol: Documented gowning and handling requirements matched to the component’s contamination sensitivity.

Medical Molding DFM Review Points Before Tooling Freeze

The period between CAD freeze and tool release is a high-risk DFM decision window. Our review focuses on resin behavior, tolerance feasibility, gating and venting strategy, and redesign triggers that can reduce T1/T2 rework loops and improve process stability in medical molding programs.

Medical resin samples reviewed for sterilization response and dimensional stability

Resin Screening for Sterilization and Stability

Material candidates can respond differently after sterilization exposure or long-term storage. We evaluate candidates against customer requirements:

  • Process Response: Screening for changes in clarity or stiffness after EtO or Gamma exposure.
  • Dimensional Impact: How resin-specific shrinkage affects steel dimensions and tolerance capability.
  • Verification: Screening against required material documentation and lot traceability needs before tool release.
Tolerance stack-up review for medical sealing and fit-critical molded features

Tolerance Feasibility on Fit and Sealing Features

Molded tolerances depend on the interaction of tool design, resin shrink, and feature geometry. Our review targets repeatable assembly:

  • Capability Review: Linking drawing requirements to achievable process capability before tool launch.
  • Sealing Interfaces: Aligning tolerance bands with shrink variability to prevent sealing drift.
  • Functional Consistency: Defining CTQ dimensions that support repeatable assembly under defined use conditions.
Gate and venting review for thin-wall medical molding features

Gating, Venting, and Wall-Thickness Transition

Early DFM decisions strongly affect fill balance and warpage risk. We review gating against visible vestige and fill logic:

  • Risk Mitigation: Checking for short-shot risk and trapped-gas marks (burn marks) in thin-rib areas.
  • Thickness Transition: Adjusting transitions to reduce residual stress, sink risk, and warpage sensitivity.
  • Venting Layout: Defining specialized inserts for micro-features to ensure gas removal during high-speed injection.
Medical part DFM review showing redesign issues before tooling freeze

Redesign Triggers Identified Before Steel Cut

Proactive design adjustments before tool release reduce rework loops and lower tooling revision risk after T1/T2 stages:

  • Tolerance Realism: Typical redesign flags include ±0.01 mm targets where material-shrink variability is larger.
  • Complexity Review: Flagging undercut complexity or sharp internal corners that compromise tool life.
  • Gating Feasibility: Redesigning non-functional cosmetic features that interfere with stable gating or ejection.

FAQ About Medical Injection Molding Validation and Supplier Qualification

What files should be submitted before quotation?

To review tooling feasibility, CTQ risk, and quotation inputs accurately, we typically require:
  • STEP File: 3D CAD model for volume analysis and DFM feasibility review.
  • 2D Drawing: For identification of critical tolerances, datums, and surface-finish callouts.
  • CTQ List: To identify which specific dimensions or assembly interfaces require heightened control.
  • Annual Volume: Expected yearly demand helps determine cavity count, tool class, and pilot vs. production tooling routes.
  • Resin & Sterilization: Specific material grades and sterilization requirements (EtO, Gamma, or Autoclave).

What documents can be reviewed before supplier approval?

Sample documents for supplier qualification can include:
  • Sample FAI: Example First Article Inspection report format and typical record content.
  • Material Certifications: Sample evidence of resin lot traceability and material identity.
  • CoC Templates: Example format for our standard Certificate of Conformance.
  • Traceability Samples: Example lot and cavity-level manufacturing history logs.
  • Trial Report: Example T1/T2 mold trial records, issue tracking, and process-setting summaries.

What kinds of medical components are suitable for molding?

Injection molding is typically suitable for components requiring repeatable geometry and production volumes that justify tooling investment, such as:
  • Fluid Delivery: Luer connectors, manifold bodies, and fluid-path fittings.
  • Housings: Handheld instrument shells and drug delivery device enclosures.
  • Mating Interfaces: Multi-way connectors and catheter overmolded hubs.
  • Criteria: Suitable parts usually combine stable resin selection, defined CTQs, and consistency needs for high-volume assembly.

When is molding not the right first-step process?

Production tooling should usually wait until geometry and CTQs are stable enough to support DFM review:
  • Unstable Design: When key CAD features, CTQ definitions, or assembly interfaces have not yet been frozen.
  • Better Process Fit: Very Low Volume or Early Iteration: CNC machining, 3D printing, or vacuum casting is usually a better pre-tooling route.
  • Recommendation: Parts should remain in CNC or prototype stages until production assumptions are stable enough for tooling release.